Celldex/$CLDX
14:30
22:10
05:45
13:25
21:00
1D1W1MYTD1Y5YMAX
About Celldex
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Ticker
$CLDX
Sector
Primary listing
Employees
186
Headquarters
Website
Celldex Metrics
BasicAdvanced
$1.8B
-
-$3.38
1.13
-
Price and volume
Market cap
$1.8B
Beta
1.13
52-week high
$30.50
52-week low
$14.40
Average daily volume
843K
Financial strength
Current ratio
13.006
Quick ratio
12.554
Long term debt to equity
0.178
Total debt to equity
0.438
Profitability
EBITDA (TTM)
-252.858
Gross margin (TTM)
-8,237.05%
Net profit margin (TTM)
-8,639.17%
Operating margin (TTM)
-9,859.22%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-21.77%
Return on equity (TTM)
-32.44%
Valuation
Price to revenue (TTM)
681.551
Price to book
2.96
Price to tangible book (TTM)
3.1
Price to free cash flow (TTM)
-9.75
Free cash flow yield (TTM)
-10.26%
Free cash flow per share (TTM)
-2.736
Growth
Revenue change (TTM)
-73.95%
Earnings per share change (TTM)
33.50%
3-year revenue growth (CAGR)
34.09%
10-year revenue growth (CAGR)
-6.64%
3-year earnings per share growth (CAGR)
14.29%
10-year earnings per share growth (CAGR)
-16.28%
What the Analysts think about Celldex
Analyst ratings (Buy, Hold, Sell) for Celldex stock.
Celldex Financial Performance
Revenues and expenses
Celldex Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Celldex stock?
Celldex (CLDX) has a market cap of $1.8B as of December 17, 2025.
What is the P/E ratio for Celldex stock?
The price to earnings (P/E) ratio for Celldex (CLDX) stock is 0 as of December 17, 2025.
Does Celldex stock pay dividends?
No, Celldex (CLDX) stock does not pay dividends to its shareholders as of December 17, 2025.
When is the next Celldex dividend payment date?
Celldex (CLDX) stock does not pay dividends to its shareholders.
What is the beta indicator for Celldex?
Celldex (CLDX) has a beta rating of 1.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.